PMID: 9169565Jun 1, 1997Paper

Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography

European Journal of Nuclear Medicine
J J ClausE A Van Royen

Abstract

Decreased muscarinic receptor binding has been suggested in single-photon emission tomography (SPET) studies of Alzheimer's disease. However, it remains unclear whether these changes are present in mildly demented patients, and the role of cortical atrophy in receptor binding assessment has not been investigated. We studied muscarinic receptor binding normalized to neostriatum with SPET using [123I]4-iododexetimide in five mildly affected patients with probable Alzheimer's disease and in five age-matched control subjects. Region of interest (ROI) analysis was performed in a consensus procedure blind to clinical diagnosis using matched magnetic resonance (MRI) images. Cortical atrophy was assessed by calculating percentages of cerebrospinal fluid in each ROI. An observer study with three observers was conducted to validate this method. Alzheimer patients showed statistically significantly less [123I]4-iododexetimide binding in left temporal and right temporo-parietal cortex compared with controls, independent of age, sex and cortical atrophy. Mean intra-observer variability was 3.6% and inter-observer results showed consistent differences in [123I]4-iododexetimide binding between observers. However, differences between patients ...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Jan 1, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·V Dolezal, S Tucek
Nov 11, 1992·JAMA : the Journal of the American Medical Association·M FarlowJ Dolan-Ureno
Jan 1, 1992·The Journal of Neuropsychiatry and Clinical Neurosciences·D R WeinbergerT N Chase
Jul 11, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H W Müller-GärtnerJ J Frost
Apr 27, 1991·Lancet·S A EaggerB J Sahakian
Apr 1, 1989·Trends in Neurosciences·T I Bonner
Dec 1, 1988·Brain : a Journal of Neurology·K PodollJ Noth
Nov 1, 1987·Neurobiology of Aging·P D Coleman, D G Flood
Mar 1, 1988·Journal of Neurochemistry·C J SmithN J Birdsall
Dec 1, 1986·Neurology·H CreaseyS I Rapoport
Nov 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·S B WallerE D London
Jun 10, 1985·Brain Research·J O RinneU K Rinne
Dec 4, 1982·Lancet·M P CaulfieldN J Birdsall
Jan 1, 1995·Molecular and Chemical Neuropathology·G Ferrari-DiLeoD D Flynn
Mar 1, 1994·Neurobiology of Aging·R S JopeR Powers
Apr 6, 1994·JAMA : the Journal of the American Medical Association·M J KnappS I Gracon
Feb 1, 1993·Psychological Medicine·J LindeboomC Jonker
Apr 1, 1997·Neurology·J J ClausE Mohr

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.